StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
SNT$2.67-3.61%
Fair $2.67+0.0%

SNT

Senstar Technologies Corporation

Industrials / Security & Protection ServicesNasdaqGM

$2.67

-0.10 (-3.61%)

Fairly Valued+0.0%Fair Value $2.67Fund rank 27/100 · Data gapFallback financials|
SA 41/C
F-Score: 6/9

FCF base 3Y

n/d

n/d CAGR · yield n/d

FCF base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 34% · confianza 18%

FCF escenarios

weak_data · normalized FCF $1.2M · quality 47.0/100

Data gap 27/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 17/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

41/100

C

Piotroski

6/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

16/100

SEC 0%

Latest source: unknownPeriods: 4Warnings: 0unknown: 4
No SEC-backed annual rows; valuation uses fallback financial data. Insufficient audited annual history (<3 SEC-backed years); composite fair value and forward targets are disabled until manually verified.
Thesis & Journal · SNTLocal privado en este navegador · Senstar Technologies Corporation
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$62M

P/E

44.5x

↑

EV/EBITDA

11.1x

↑

ROE

7.4%

↑

Gross Margin

65.5%

↑

Debt/Equity

0.01

↓
52-Week Range$3
$3$5

TradingView lightweight chart

SNT price, volumen y niveles de valoración

Último $2.670Periodo -10.2%
Fair value: $2.670

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2022–2025 · 3 años de histórico normalizado

Revenue CAGR

+0.8%

FCF CAGR

—

FCF margin

3.3%

FCF / Net income

0.37x

Latest source

Provider fallback

Margin decomposition

Último año: revenue $36.4M · net income $3.2M · FCF $1.2M

2022-FY → 2025-FY

Gross margin

65.5%+5.1% pts

Operating margin

8.3%+4.1% pts

Net margin

8.8%-1.9% pts

FCF margin

3.3%+30.5% pts
MetricTTM
2025
2024
2023
2022
Income Statement
Revenue$36.4M$36.4M$35.8M$32.8M$35.6M
Net Income$3.2M$3.2M$2.6M$-1.3M$3.8M
EBITDA$3.7M$3.7M$4.6M$-348000.00$3.3M
EPS0.140.140.11-0.060.16
Gross Margin65.5%65.5%64.1%57.5%60.5%
Operating Margin8.3%8.3%10.9%-3.9%4.2%
Net Margin8.8%8.8%7.4%-3.9%10.8%
Balance Sheet
Debt/Equity0.010.010.010.020.03
Current Ratio3.143.14———
Cash Flow
Free Cash Flow$1.2M$1.2M$6.4M$-120000.00$-9.7M
Returns
ROE7.4%7.4%7.0%-3.5%10.2%
Valuation
P/E44.5044.5033.64—8.38
EV/EBITDA11.0811.0814.37—5.20
P/B1.451.452.290.750.83
Growth & Yield
Revenue Growth1.7%1.7%9.0%-7.8%—
EPS Growth27.3%27.3%283.3%-137.5%—

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Leverage & Liquidity

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%

3Y implied EPS CAGR

19.2%

exigente

EPS terminal req.

$0.24

Spread vs growth

8.1%

5Y implied EPS CAGR

15.4%

exigente

EPS terminal req.

$0.29

Spread vs growth

11.9%

10Y implied EPS CAGR

12.7%

razonable

EPS terminal req.

$0.46

Spread vs growth

14.6%

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · 1Y approxreconcilia total -35.4%

Total return

-35.4%

Start / end P/E

37.5x → 19.1x

EPS bridge

0.11 → 0.14

Residual

-13.4%

EPS growth+27.3%
Multiple rerating-49.2%
Dividend+0.0%
Residual / FX / buybacks / cross-term-13.4%

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.